Resectoscopic treatment of atypical endometrial polyps in fertile women

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 4, 2008, Pages 365.e1-365.e3

  Scrimin, Federica ^a   Wiesenfeld, Uri ^a   Candiotto, Alberto ^a   Inglese, Stefania ^a   Ronfani, Luca ^a   Guaschino, Secondo ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

atypical endometrial polyp; fertile women; hysteroscopic resection; levonorgestrel IUD

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; ENDOMETRIAL DISEASE; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM POLYP; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; OPEN STUDY; POLYPECTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 52949134507     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.03.041     Document Type: Article

References (12)

1. Scrimin F., Mangino F., Wiesenfeld U., Candiotto A., and Guaschino S. Is resectoscopic treatment of atypical endometrial polyps a safe option?. Am J Obstet Gynecol 195 (2006) 1328-1330
2. Randall T.C., and Kurman R.J. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90 (1997) 434-440
3. Scott R.B. The elusive endometrial polyp. Obstet Gynecol 1 (1953) 212-218
4. Savelli L., De Iaco P., Santini D., et al. Histopathologic features of and risk factors for benignity, hyperplasia and cancer in endometrial polyps. Am J Obstet Gynecol 188 (2003) 927-931
5. Kurman R.J., Kaminski P.F., and Norris H.G. The behavior of endometrial hyperplasia: a long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 (1985) 403-412
6. Kurman R.J., and Norris H.G. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49 (1982) 2547-2559
7. Broder M.S., Kanouse D.E., Mittman B.S., and Bernstein S.J. The appropriateness of recommendations for hysterectomy. Obstet Gynecol 95 (2000) 199-205
8. Lefebvre G., Allaire C., Jeffrey J., et al. SOGC clinical guidelines: hysterectomy. J Obstet Gynaecol Can 24 (2002) 37-61
9. Gardner F.J.E., Konje J.C., Abrams K.R., et al. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel- releasing intrauterine system: a randomised controlled trial. Lancet 356 (2000) 1711-1717
10. Luukkainen T., and Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 52 (1995) 269-276
11. Andersson K., Mattsson L.A., Rybo G., and Stradberg E. Intrauterine release of levonorgestrel: a new way of adding progesterone in hormone replacement therapy. Obstet Gynecol 79 (1992) 963-967
12. Bernstein S.J., Fiske M.E., McGlynn E.A., Glifford D.S., and Southern California Health Policy Research Consortium. Hysterectomy: a review of the literature on indications, effectiveness and risks (1997), Rand Corp, Santa Monica (CA) MR-592/2.